List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 627 studies with search of:   Canada, Saskatchewan
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril
2 Completed Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS)
Condition: Atrial Fibrillation
Interventions: Drug: SR34006 (idraparinux sodium) Injection;   Drug: vitamin K antagonist (warfarin or acenocoumarol) tablets
3 Completed Canadians Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration
Condition: Hypercholesterolemia
Intervention: Drug: atorvastatin
4 Terminated Study In Asthma Control
Condition: Asthma
Intervention: Drug: salmeterol xinafoate/fluticasone propionate
5 Recruiting A Diabetes Study to Treat A Population Previously Not at Target
Condition: Type 2 Diabetes
Intervention: Drug: Rosuvastatin
6 Completed Spiriva® Assessment of FEV1 (SAFE)
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Tiotropium (Spiriva®)
7 Completed AVANDAMET Versus Metformin For Type 2 Diabetes Mellitus
Condition: Non-Insulin-Dependent Diabetes Mellitus
Intervention: Drug: rosiglitazone/metformin
8 Recruiting A 5-Year Registry Study of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Condition: Crohn's Disease
Intervention: Drug: adalimumab
9 Completed SMOOTH - Blood Pressure Control in Diabetic/Obese Patients
Conditions: Hypertension;   Diabetes Mellitus, Type 2
Interventions: Drug: telmisartan combined with hydrochlorothiazide (80/12.5 mg);   Drug: valsartan combined with hydrochlorothiazide (160/12.5mg)
10 Recruiting To Compare SH T00658ID to Ortho Tri-Cyclen Lo (US/Canada)
Condition: Oral Contraceptive
Interventions: Drug: Qlaira (BAY86-5027, SH T00658ID);   Drug: Ortho Tri Cyclen Lo
11 Completed Warfarin and Antiplatelet Therapy in Chronic Heart Failure
Condition: Heart Failure
Interventions: Drug: Warfarin titrated to an INR of 2.5-3.0;   Drug: Aspirin;   Drug: Clopidogrel
12 Terminated [S,S]-Reboxetine Add-On Trial
Condition: Pain
Intervention: Drug: [S,S]-Reboxetine
13 Completed Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: FOLFOX regimen;   Drug: fluorouracil;   Drug: leucovorin calcium;   Drug: oxaliplatin
14 Active, not recruiting ARISE – Aggressive Reduction of Inflammation Stops Events
Conditions: Atherosclerosis;   Coronary Artery Disease;   Myocardial Infarction;   Unstable Angina
Intervention: Drug: AGI-1067
15 Active, not recruiting Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Cerebrovascular Accident
Interventions: Drug: Dabigatran etexilate;   Drug: Warfarin
16 Recruiting A Canadian Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With Schizophrenia
Condition: Schizophrenia
Intervention: Drug: Quetiapine Fumarate Extended- Release
17 Completed Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma
Conditions: Brain and Central Nervous System Tumors;   Lymphoma;   Neuroblastoma;   Retinoblastoma;   Sarcoma;   Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Drug: becatecarin
18 Completed Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Condition: Leukemia
Interventions: Drug: asparaginase;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: dexamethasone;   Drug: doxorubicin hydrochloride;   Drug: leucovorin calcium;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: nelarabine;   Drug: pegaspargase;   Drug: prednisone;   Drug: thioguanine;   Drug: vincristine sulfate;   Procedure: radiation therapy
19 Suspended Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: cisplatin;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: dexamethasone;   Drug: doxorubicin hydrochloride;   Drug: etoposide phosphate;   Drug: filgrastim;   Drug: ifosfamide;   Drug: prednisone;   Drug: vincristine sulfate;   Drug: vinorelbine ditartrate;   Procedure: radiation therapy
20 Recruiting Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia
Condition: Leukemia
Interventions: Drug: cyclophosphamide;   Drug: cytarabine;   Drug: dexamethasone;   Drug: doxorubicin hydrochloride;   Drug: leucovorin calcium;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: nelarabine;   Drug: pegaspargase;   Drug: thioguanine;   Drug: vincristine sulfate;   Procedure: radiation therapy

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services